To increase awareness about potential complications in patients implanted with both programmable cerebrospinal fluid (CSF) shunt systems and some hearing implants that contain magnets, such as cochlear implants, bone conduction hearing devices, or middle ear hearing devices, the U.S. Food and Drug Administration (FDA) issued a letter to healthcare providers on July 16.

According to the FDA letter, magnetic interactions between these devices may occur when implanted in close proximity to each other. Read about it on The Hearing Review.